CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
about
Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.A Systems Medicine Approach Reveals Disordered Immune System and Lipid Metabolism in Multiple Sclerosis Patients.Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis.
P2860
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CSF Proteomics Identifies Spec ...... le Sclerosis Clinical Subtypes
@ast
CSF Proteomics Identifies Spec ...... le Sclerosis Clinical Subtypes
@en
type
label
CSF Proteomics Identifies Spec ...... le Sclerosis Clinical Subtypes
@ast
CSF Proteomics Identifies Spec ...... le Sclerosis Clinical Subtypes
@en
prefLabel
CSF Proteomics Identifies Spec ...... le Sclerosis Clinical Subtypes
@ast
CSF Proteomics Identifies Spec ...... le Sclerosis Clinical Subtypes
@en
P2093
P2860
P1433
P1476
CSF Proteomics Identifies Spec ...... le Sclerosis Clinical Subtypes
@en
P2093
Aksel Siva
Eda Tahir Turanlı
Melih Tütüncü
Nuri Onat Demirci
O Uğur Sezerman
Sabahattin Saip
Timucin Avsar
Uğur Uygunoğlu
İlknur Melis Durası
P2860
P304
P356
10.1371/JOURNAL.PONE.0122045
P407
P577
2015-05-05T00:00:00Z